InMed Pharmaceuticals Inc. (INM)
NASDAQ · Healthcare
InMed Pharmaceuticals Inc. Shareholder Equity 2021–2025
InMed Pharmaceuticals Inc. annual shareholder equity history from 2021 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- InMed Pharmaceuticals Inc. shareholder equity as of June 30, 2025: 13.4M, a 45.93% increase year-over-year.
- InMed Pharmaceuticals Inc. shareholder equity for 2025 were 13.4M, a 45.93% increase from 2024.
- InMed Pharmaceuticals Inc. shareholder equity for 2024 were 9.2M, a 23.85% decrease from 2023.
- InMed Pharmaceuticals Inc. shareholder equity for 2023 were 12.1M, a 33.17% increase from 2022.
- InMed Pharmaceuticals Inc. shareholder equity for 2022 were 9.1M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| InMed Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $13 |
| 2024 | $9 |
| 2023 | $12 |
| 2022 | $9 |
| 2021 | $7 |
InMed Pharmaceuticals Inc. Shareholder Equity — FAQ
InMed Pharmaceuticals Inc. (INM) shareholder equity over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INM's shareholder equity history?
The chart and table above show InMed Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.